1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

SkinMedica

Anonymous board for SkinMedica


Sort By:
Title ↓
Replies Views
Last Message
  1. Anonymous
    Replies:
    7
    Views:
    3,500
  2. Anonymous
    Replies:
    6
    Views:
    3,924
  3. Anonymous
    Replies:
    4
    Views:
    3,941
  4. Anonymous
    Replies:
    35
    Views:
    5,481
  5. Anonymous
    Replies:
    8
    Views:
    5,015
  6. Anonymous
    Replies:
    6
    Views:
    3,304
  7. Anonymous
    Replies:
    0
    Views:
    1,781
  8. Anonymous
    Replies:
    6
    Views:
    4,061
  9. Anonymous
    Replies:
    4
    Views:
    2,753
  10. Anonymous
    Replies:
    14
    Views:
    1,974
  11. Anonymous
    Replies:
    23
    Views:
    3,252
  12. Anonymous
    Replies:
    0
    Views:
    1,865
  13. Anonymous
    Replies:
    13
    Views:
    4,166
  14. Anonymous
    Replies:
    4
    Views:
    3,908
  15. Anonymous
    Replies:
    31
    Views:
    34,598
  16. Anonymous
    Replies:
    3
    Views:
    2,171
  17. Anonymous
    Replies:
    19
    Views:
    3,122
  18. Anonymous
    Replies:
    10
    Views:
    4,731
  19. Anonymous
    Replies:
    7
    Views:
    3,215
  20. Anonymous
    Replies:
    689
    Views:
    110,458

Thread Display Options

Loading...